Imagion Biosystems L

IBXXF

$0.01May 03, 2021Apr 29, 2026
Health CareHealth Care Equipment & SuppliesHealth Care Equipment$7M
MVM
+$0.0M
PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Chart Start
$4.00
2021
Since 2021
-99.8%
vs SPY +70.2%
All-time High
$12.40 · Sep 2021
-99.9% from peak
MVM Rank
#89 of 192
Health Care Equipment

Imagion Biosystems L has returned -99.8% from $4.00 since 2021, trailing SPY's +70.2% over the same period. The stock hit an all-time high of $12.40 in Sep 2021 and is currently 99.9% below that level. 2 news events tracked with market reaction data.

How to use this page
1Company Research Snapshot

Expand to read Wikipedia-sourced background on the company. Click any linked term to explore it inline — no page reload.

2Company Q&A

Common questions answered from real data: performance vs SPY, market cap, profitability, CEO, dividends, and more.

3News & Events

Every dot on the chart is a news event. The return shown is market-adjusted (vs SPY). Green = stock outperformed. Red = underperformed. Dot size = magnitude of reaction.

Show ▼
Company Q&AShow ▼
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2026-02-24-1.6%newsGlobeNewswirePresenting on Emerging Growth Conference 90 Day 1 on February 25; Register to live stream
2026-02-03+1.3%legalBusiness WireMedical-imaging company Imagion Biosystems Lodges IND with FDA for Phase 2 Trial of MagSense® HER2 targeted imaging agent
tickerdossier.comtickerdossier.substack.com